Victory Capital Management Inc Generation Bio Co. Transaction History

Victory Capital Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$4.68 - $8.34 $6,996 - $12,468	1,495 Added 8.44%	19,210 $102,000
Q2 2022 Aug 01, 2022	SELL	$4.87 - $9.41 $102 - $197	-21 Reduced 0.12%	17,715 $116,000
Q1 2022 May 04, 2022	SELL	$4.16 - $7.76 $327,953 - $611,759	-78,835 Reduced 81.63%	17,736 $112,000
Q4 2021 Feb 07, 2022	SELL	$5.99 - $24.97 $7.05 Million - $29.4 Million	-1,176,976 Reduced 92.42%	96,571 $683,000
Q3 2021 Nov 02, 2021	BUY	$20.0 - $27.43 $3.05 Million - $4.18 Million	152,567 Added 13.61%	1,273,547 $31.9 Million
Q2 2021 Aug 03, 2021	BUY	$24.34 - $38.34 $929,106 - $1.46 Million	38,172 Added 3.53%	1,120,980 $30.2 Million
Q1 2021 May 04, 2021	BUY	$24.74 - $40.2 $8.99 Million - $14.6 Million	363,459 Added 50.53%	1,082,808 $30.8 Million
Q4 2020 Feb 01, 2021	SELL	$21.68 - $51.61 $3.2 Million - $7.62 Million	-147,648 Reduced 17.03%	719,349 $20.4 Million
Q3 2020 Nov 09, 2020	BUY	$18.07 - $31.84 $330,753 - $582,799	18,304 Added 2.16%	866,997 $26.8 Million
Q2 2020 Aug 07, 2020	BUY	$20.1 - $24.69 $17.1 Million - $21 Million	848,693 New	848,693 $17.8 Million

49.6M

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $67.9M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.